Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Terminated1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT01137162Terminated
Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors
Anal, Colon, and Rectal CancersColon CancerColon/Rectal Cancer+17 more
Principalinvestigator
NCT01644097Phase 2Withdrawn
Probiotic Supplementation in Preventing Treatment-Related Diarrhea in Patients With Cancer Undergoing Chemotherapy
DiarrheaUnspecified Adult Solid Tumor, Protocol Specific
Principalinvestigator

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

George Albert Fisher M.D. Ph.D.

Stanford University

Very Similar
6 trials

Shared therapeutic areas:

Anal, Colon, and Rectal CancersColorectal NeoplasmsCancer of Colon+17 more

Worked with same sponsors:

Stanford University
Collaborated on 1 trial
Similarity Score204%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Lung CancerUnspecified Adult Solid Tumor, Protocol SpecificCancer of Head and Neck

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

James L Gulley, M.D.

National Cancer Institute (NCI)

Related
18 trials

Shared therapeutic areas:

Lung CancerCancer of ColonColonic Neoplasms

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Cancer of ColonCancer of Head and NeckLung Cancer
Similarity Score4%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Cancer of ColonColorectal Neoplasms
Similarity Score3%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Lung CancerCancer of Colon

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Cancer of ColonCancer of Head and Neck
Similarity Score3%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Lung CancerCancer of Head and Neck
Similarity Score3%

Ajay Goel, PhD

City of Hope Medical Center

Related
24 trials

Shared therapeutic areas:

Colorectal NeoplasmsCancer of Colon
Similarity Score3%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Lung CancerCancer of Head and Neck
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT01137162PrincipalInvestigator

Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors

Anal, Colon, and Rectal CancersColon CancerColon/Rectal Cancer+17 more
Terminated
NCT01644097Phase 2PrincipalInvestigator

Probiotic Supplementation in Preventing Treatment-Related Diarrhea in Patients With Cancer Undergoing Chemotherapy

DiarrheaUnspecified Adult Solid Tumor, Protocol Specific
Withdrawn

All 2 trials loaded